 |
|
 |
 |

Home > Company Index > Drugs > Drug Delivery > Control Delivery Systems, Inc.
 |
Control Delivery Systems, Inc. |
 |
 |
 |
PROFILE |
 |
Control Delivery Systems manufactures and sells a time-released drug delivery product, called the Aeon system, through a marketing agreement with Bausch & Lomb. The company's first product that utilizes the system, called Vitrasert, has already gained FDA approval for treatment of cytomegalovirus (CMV) retinitis, a blinding eye disease common among AIDS patients. Vitrasert is designed to be implanted in the body so it can utilize a smaller drug dosage to help prevent side effects. The company has products for pain management, and conditions such as diabetic eye disease, brain tumors, age-related macular degeneration, and osteoarthritis, in its pipeline.
COMPETITION |
 |
Chiron Corporation (CHIR)
Isis Pharmaceuticals, Inc. (ISIP)
Pfizer Inc (PFE)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
1999 Sales (mil.): 2.80
1-Yr. Sales Growth: 149.8%
KEY PEOPLE |
 |
Paul Ashton
CEO
Michael D. Mays
CFO
CONTACT INFO |
 |
313 Pleasant St.
Watertown, MA 02472
US
Phone: 617-926-5000
Fax: 617-926-5050
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |